Quantum BioPharma Ltd.
QNTM
$3.89
-$0.16-3.95%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 93.06% | 118.38% | -29.16% | -56.82% | -50.83% |
| Total Receivables | -9.78% | -92.13% | -9.15% | -5.27% | -10.38% |
| Inventory | -1.15% | -32.86% | 0.91% | -18.10% | -19.88% |
| Prepaid Expenses | 398.04% | -61.07% | -90.76% | 260.51% | 176.35% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 43.32% | -26.73% | 2.49% | 83.51% | 211.94% |
| Total Current Assets | 60.06% | -30.66% | -9.67% | 4.15% | -17.60% |
|
|
|||||
| Total Current Assets | 60.06% | -30.66% | -9.67% | 4.15% | -17.60% |
| Net Property, Plant & Equipment | -12.88% | -11.27% | -16.39% | 108.78% | -16.18% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.30% | -2.29% | -2.25% | -2.17% | -2.10% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 33.74% | -21.14% | -7.48% | 2.85% | -13.12% |
|
|
|||||
| Total Accounts Payable | -0.19% | -24.05% | 39.46% | 41.64% | -59.41% |
| Total Accrued Expenses | -26.69% | 48.85% | 11.86% | 27.57% | -6.45% |
| Short-term Debt | -76.89% | -34.16% | 1.58% | 78.74% | 75.75% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.08% | -1.05% | 81.47% | 66.72% | -6.61% |
| Total Finance Division Other Current Liabilities | -- | -- | -99.98% | 16.18% | 349.55% |
| Total Other Current Liabilities | -- | -- | -99.98% | 16.18% | 349.55% |
| Total Current Liabilities | 169.81% | -8.85% | -49.84% | 28.09% | 54.88% |
|
|
|||||
| Total Current Liabilities | 169.81% | -8.85% | -49.84% | 28.09% | 54.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -76.89% | -34.16% | 1.58% | 78.74% | 75.75% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 169.81% | -8.85% | -49.84% | 28.09% | 54.88% |
|
|
|||||
| Common Stock & APIC | 3.47% | 1.24% | 5.23% | 4.08% | 1.90% |
| Retained Earnings | -6.84% | -1.55% | -2.80% | -5.12% | -4.98% |
| Treasury Stock & Other | 111.33% | -92.22% | 12.53% | -18.71% | -30.37% |
| Total Common Equity | -91.40% | -19.97% | 129.87% | -34.34% | -50.07% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -91.40% | -19.97% | 129.87% | -34.34% | -50.07% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -10.60% | -59.08% | 33.28% | -42.64% | -15.69% |
| Total Equity | -127.83% | -32.03% | 266.72% | -54.80% | -56.62% |
|
|
|||||